- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
008930
KSC
Week ended 07 Aug 2026
Weekly Investor Report
Hanmi Science Co., Ltd. · Healthcare · Medical Distribution
Latest close
44,650 KRW
24.5%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 21.2% above the Trend Line and sits at 64.6% of its 52-week range. The latest completed week returned 24.5%, after a 33.7% four-week move. The latest news-sentiment score is 50/100.
Setup score
51
out of 100
Latest Close
44,650 KRW
7 Aug 2026
1W Return
24.5%
latest completed week
4W Return
33.7%
short-term follow-through
12W Return
27.6%
quarterly tape
Trend Breadth
28.8%
15 of 52 weeks active
Volume Ratio
2.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
24.5%
Latest completed week; four-week move 33.7%.
Indicator stack
16/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 21.2% above the Trend Line and sits at 64.6% of its 52-week range. The latest completed week returned 24.5%, after a 33.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1312-week average 0.14
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.13Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 33.7% over four weeks, 27.6% over 12 weeks, and 3.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year15
Trend breadth28.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.50Latest activity-pressure read.
Pressure change154.9%Four-week change in activity pressure.
Leadership-8.00Latest relative-leadership reading.
RS change83.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-18.9%Distance below the 52-week high.
13-week volatility10.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+24.5%Week of 7 Aug.
Worst week-12.0%Week of 26 Jun.
Latest week+24.5%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains6
Flat weeks0
Modest losses9
Sharp losses7
Recent vol10.2%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorKR Healthcare
4-week rank1 / 63
Group average4.4%
Trend breadth1.6%
Trend1.6%active weekly trend signals
MD9.5%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
IndustryKR Medical Distribution
4-week rank1 / 1
Group average33.7%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape42/100
Trend, activity pressure, participation, and risk combine to a 42/100 tape read.
Indicator analysis14/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.13; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
Price to earnings forward of Hanmi Science Co., Ltd – KRX:008930 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 44,650 KRW | 24.5% | 36,840 KRW | 35,132 KRW | 0.50 | -8.00 | 1.4M | Off |
| 31 Jul 2026 | 35,850 KRW | 3.6% | 36,622 KRW | 35,091 KRW | 0.11 | -30.98 | 792.6K | Off |
| 24 Jul 2026 | 34,600 KRW | 5.8% | 36,634 KRW | 35,075 KRW | -0.26 | -35.74 | 789.4K | Off |
| 17 Jul 2026 | 32,700 KRW | -2.1% | 36,704 KRW | 35,056 KRW | -0.65 | -41.85 | 774.5K | Off |
| 10 Jul 2026 | 33,400 KRW | 5.0% | 36,853 KRW | 35,057 KRW | -0.90 | -47.13 | 1.9M | Off |
| 3 Jul 2026 | 31,800 KRW | 21.8% | 36,998 KRW | 35,043 KRW | -1.26 | -54.53 | 231.9K | Off |
| 26 Jun 2026 | 26,100 KRW | -12.0% | 37,160 KRW | 35,031 KRW | -1.40 | -64.87 | 92.5K | Off |
| 19 Jun 2026 | 29,650 KRW | -1.5% | 37,575 KRW | 35,071 KRW | -1.38 | -63.81 | 102.5K | Off |
| 12 Jun 2026 | 30,100 KRW | -4.9% | 37,838 KRW | 35,091 KRW | -1.37 | -59.99 | 73.6K | Off |
| 5 Jun 2026 | 31,650 KRW | -0.3% | 38,183 KRW | 35,115 KRW | -1.32 | -58.91 | 106.5K | Off |
| 29 May 2026 | 31,750 KRW | -5.9% | 38,418 KRW | 35,142 KRW | -1.23 | -61.04 | 445.2K | Off |
| 22 May 2026 | 33,750 KRW | -3.6% | 38,662 KRW | 35,171 KRW | -1.11 | -56.09 | 723.9K | Off |
| 15 May 2026 | 35,000 KRW | -5.7% | 38,774 KRW | 35,182 KRW | -0.90 | -53.08 | 827.6K | Off |
| 8 May 2026 | 37,100 KRW | -1.6% | 38,846 KRW | 35,194 KRW | -0.68 | -51.15 | 415.1K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.